Ligustrazine with telmisartan mitigates the progression of diabetic cardiomyopathy by reducing ER stress, apoptosis, and myocardial fibrosis
- DOI
- 10.1007/s11010-026-05740-6
- Published
- 2026-09-16
- Container
- Molecular and Cellular Biochemistry
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11010-026-05740-6,
title = {Ligustrazine with telmisartan mitigates the progression of diabetic cardiomyopathy by reducing ER stress, apoptosis, and myocardial fibrosis},
author = {Mansi Vinodkumar Trivedi and Hemant R. Jadhav and Anil Bhanudas Gaikwad},
year = {2026},
journal = {Molecular and Cellular Biochemistry},
doi = {10.1007/s11010-026-05740-6},
url = {https://doi.org/10.1007/s11010-026-05740-6}
}RIS
TY - JOUR TI - Ligustrazine with telmisartan mitigates the progression of diabetic cardiomyopathy by reducing ER stress, apoptosis, and myocardial fibrosis AU - Mansi Vinodkumar Trivedi AU - Hemant R. Jadhav AU - Anil Bhanudas Gaikwad PY - 2026 JO - Molecular and Cellular Biochemistry DO - 10.1007/s11010-026-05740-6 UR - https://doi.org/10.1007/s11010-026-05740-6 ER -
APA
Trivedi, M. V., Jadhav, H. R., & Gaikwad, A. B. (2026). Ligustrazine with telmisartan mitigates the progression of diabetic cardiomyopathy by reducing ER stress, apoptosis, and myocardial fibrosis. Molecular and Cellular Biochemistry. https://doi.org/10.1007/s11010-026-05740-6
Source records
- crossref · retrieved 2026-09-25T08:53:06.001Z